The firm's CEO said that the test must undergo additional clinical studies, but it could be available from a CLIA-certified lab in about a year and a half.
The researchers won a $386,599 NIH grant to evaluate the usefulness of measuring known markers of the disease in saliva and to identify potential new markers.
The partners will use Immunovia's antibody array platform for the discovery of diagnostic biomarkers associated with four autoimmune diseases.
Bio-Rad said that the Visia platform offers a standardized and automated workflow needed by laboratories to handle ever-increasing immunofluorescence workloads.
Kindstar has been granted exclusive rights to market the SLE-Key Rule-Out test in China, which will be the initial product offering stemming from the partnership.
Quanterix's Simoa single-molecule detection method combined with high-affinity antibodies detected minute levels of problematic interferon alpha proteins, a study said.
The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.